학술논문
Efficacy of Definitive Radiotherapy for Patients with Clinical Stage IIIB or IIIC Lung Adenocarcinoma and Epidermal Growth Factor Receptor (EGFR) Mutations Treated Using First- or Second-Generation EGFR Tyrosine Kinase Inhibitors.
Document Type
Article
Source
Canadian Respiratory Journal; 3/5/2024, Vol. 2024, p1-10, 10p
Subject
Language
ISSN
11982241